Quick charity verification for Angioma Alliance (EIN: 20600697)
Verdict: Angioma Alliance appears trustworthy
92/100Mission Score
$1.4MRevenue
$1.1MAssets
1Red Flags
5Strengths
Red Flags
Expenses slightly exceeded revenue in the 2023 filing ($1,369,269 vs. $1,292,022), which warrants monitoring to ensure it's not a recurring trend.
Strengths
Consistent and significant revenue growth over a decade, from $271,692 in 2014 to $1,292,022 in 2023.
Zero officer compensation reported across all 13 filings, indicating strong financial transparency and dedication to mission.
Healthy and growing asset base, increasing from $237,322 in 2014 to $1,134,529 in 2023.
Low and stable liabilities, suggesting good financial management.
Strong program focus implied by the absence of executive compensation.
Spending Breakdown
How Angioma Alliance allocates its funds across programs, administration, and fundraising.
85%
Program Spending
Healthy — majority goes to mission
10%
Admin Costs
Reasonable — admin costs in check
5%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.
How to Interpret This Report
What Red Flags Mean
Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.
What Mission Score Measures
The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.
Using This Data for Donation Decisions
Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.
Frequently Asked Questions about Angioma Alliance
Is Angioma Alliance a legitimate charity?
Based on AI analysis of IRS 990 filings, Angioma Alliance (EIN: 20600697) appears trustworthy. Mission Score: 92/100. 1 red flag identified, 5 strengths noted.
Is Angioma Alliance a good charity to donate to?
Angioma Alliance has a Mission Score of 92/100. Revenue: $1.4M. Assets: $1.1M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.
What is the EIN for Angioma Alliance?
The Employer Identification Number (EIN) for Angioma Alliance is 20600697. This is the unique tax ID assigned by the IRS.
What is a Mission Score?
The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.
How does Angioma Alliance spend its money?
Angioma Alliance allocates 85% to programs, 10% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.
How can I verify Angioma Alliance's tax-exempt status?
You can verify Angioma Alliance's tax-exempt status using EIN 20600697 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.
AI Transparency Report
Angioma Alliance demonstrates a strong commitment to its mission, as evidenced by its consistent growth in revenue and assets over the past decade. The organization's revenue has grown from $271,692 in 2014 to $1,292,022 in 2023, indicating increasing support for its cause. While the 2023 filing shows expenses slightly exceeding revenue ($1,369,269 vs. $1,292,022), this appears to be an anomaly in a trend of generally positive net income, and the organization maintains healthy assets of $1,134,529. The consistent reporting of 0% officer compensation across all filings is a significant indicator of financial transparency and a focus on directing funds towards programs rather than executive salaries.
The organization's financial health appears robust, with assets consistently growing alongside revenue. The liabilities have remained relatively low and stable, suggesting good financial management. The absence of officer compensation is a notable strength, indicating that leadership is either volunteer-based or compensated through other means not classified as officer compensation, which enhances the perception of efficiency and dedication to the mission. Overall, Angioma Alliance presents as a financially sound and transparent organization.